22 related articles for article (PubMed ID: 1952561)
1. Enhancement of antigen-induced bronchoconstriction in the guinea pig after intravascular complement activation with cobra venom factor.
Regal JF
Int Arch Allergy Appl Immunol; 1990; 91(1):86-94. PubMed ID: 2312187
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antigen-induced bronchoconstriction after intravascular complement activation with cobra venom factor. Reversal by granulocyte depletion.
Regal JF; Fraser DG; Anderson DE; Solem LE
J Immunol; 1993 Apr; 150(8 Pt 1):3496-505. PubMed ID: 8468484
[TBL] [Abstract][Full Text] [Related]
3. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
Regal JF; Fraser DG; Toth CA
J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173
[TBL] [Abstract][Full Text] [Related]
4. The oligosaccharide chains of cobra venom factor are required for complement activation.
Grier AH; Vogel CW
Mol Immunol; 1989 Jun; 26(6):563-74. PubMed ID: 2770749
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic analysis of platelet activating factor16- and 18-induced bronchoconstriction in the guinea pig.
Krell RD; McCarthy M
Ann N Y Acad Sci; 1991; 629():176-92. PubMed ID: 1952549
[No Abstract] [Full Text] [Related]
6. Structure and function of cobra venom factor, the complement-activating protein in cobra venom.
Vogel CW; Bredehorst R; Fritzinger DC; Grunwald T; Ziegelmüller P; Kock MA
Adv Exp Med Biol; 1996; 391():97-114. PubMed ID: 8726051
[No Abstract] [Full Text] [Related]
7. Recombinant cobra venom factor.
Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
[TBL] [Abstract][Full Text] [Related]
8. White cells and the ovary--incidental invaders or essential effectors?
Norman RJ; Brannstrom M
J Endocrinol; 1994 Mar; 140(3):333-6. PubMed ID: 8182359
[No Abstract] [Full Text] [Related]
9. Role of circulating white blood cells in the enhancement of antigen-induced bronchoconstriction after intravascular complement activation with cobra venom factor.
Regal JF; Fraser DG
Ann N Y Acad Sci; 1991; 629():388-91. PubMed ID: 1952561
[No Abstract] [Full Text] [Related]
10. Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases.
Vogel CW; Fritzinger DC; Gorsuch WB; Stahl GL
Thromb Haemost; 2015 Mar; 113(3):548-52. PubMed ID: 25031089
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
